International Journal of Infectious Diseases
Volume 13, Issue 3 , Pages 362-368 , May 2009

Treatment interruptions and duration associated with default among new patients with tuberculosis in six regions of Russia

  • W. Jakubowiak

      Affiliations

    • WHO TB Control Programme in the Russian Federation, Office of the Special Representative of the World Health Organization Director-General in Russia, 28, Ostozhenka St., 119034 Moscow, Russian Federation
    • Corresponding Author InformationCorresponding author. Tel.: +7 495 787 2116; fax: +7 495 787 2149.
    • ,
  • E. Bogorodskaya

      Affiliations

    • Research Institute of Phthisiopulmonology of the Sechenov Moscow Medical Academy, Moscow, Russian Federation
    • ,
  • S. Borisov

      Affiliations

    • Research Institute of Phthisiopulmonology of the Sechenov Moscow Medical Academy, Moscow, Russian Federation
    • ,
  • I. Danilova

      Affiliations

    • WHO TB Control Programme in the Russian Federation, Office of the Special Representative of the World Health Organization Director-General in Russia, 28, Ostozhenka St., 119034 Moscow, Russian Federation
    • ,
  • E. Kourbatova

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

Received 7 January 2008 ,Revised 16 June 2008 ,Accepted 12 July 2008.

References 

  1. Shilova MV, Dye C. The resurgence of tuberculosis in Russia. Philos Trans R Soc Lond B Biol Sci. 2001;356:1069–1075
  2. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006.362. Geneva, World Health Organization; 2006. Available at: http://www.who.int/tb/publications/global_report/2006/en/index.html (accessed September 2008).
  3. Analytical review of the situation with tuberculosis in the Russian Federation, 2004: characteristics of epidemiological process and TB services. Moscow: Ministry of Health and Social Development of the Russian Federation, Central Research Institute of Public Health and IT, and Research Institute of Phthisiopulmonology of the Sechenov Moscow Medical Academy; 2006 (in Russian).
  4. Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis. 2002;6:406–414
  5. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax. 2005;60:130–135
  6. Anti-tuberculosis drug resistance in the world. Report No. 3. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1999-2002. WHO/HTM/TB/2004.343. Geneva, World Health Organization; 2004. Available at: http://www.who.int/tb/publications/who_htm_tb_2004_343/en/ (accessed September 2008).
  7. Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis. 1998;2:10–15
  8. Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007;11:1–8
  9. Centers for Disease Control and Prevention (CDC). Tuberculosis treatment interruptions—Ivanovo Oblast, Russian Federation, 1999. MMWR Morb Mortal Wkly Rep 2001;50:201–4.
  10. Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med. 1997;102:164–170
  11. Addington WW. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest. 1979;76:741–743
  12. Davidson H, Schluger NW, Feldman PH, Valentine DP, Telzak EE, Laufer FN. The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Int J Tuberc Lung Dis. 2000;4:860–865
  13. On implementation of recording and reporting documentation for TB monitoring. Moscow, Russia: Ministry of Health of the Russian Federation; 2004 (in Russian).
  14. On improvement of TB control activities in the Russian Federation. Moscow, Russia: Ministry of Health of the Russian Federation; 2003 (in Russian).
  15. World Health Organization . Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213–215
  16. On approval of protocols of the treatment of TB patients. Moscow, Russia: Ministry of Health of the Russian Federation; 1998 (in Russian).
  17. Guidelines on the forming of dispensary follow-up groups. Moscow, Russia: Ministry of Health of the Russian Federation, Attachment to the Ministry of Health and Medical Industry of the Russian Federation; 1995 (in Russian).
  18. Marx FM, Atun RA, Jakubowiak W, McKee M, Coker RJ. Reform of tuberculosis control and DOTS within Russian public health systems: an ecological study. Eur J Public Health. 2007;17:98–103
  19. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002;6:780–788
  20. Chang KC, Leung CC, Tam CM. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis. 2004;8:1492–1498
  21. Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, et al. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis. 2004;8:598–602
  22. Kourbatova EV, Borodulin BE, Borodulina EA, del Rio C, Blumberg HM, Leonard MK. Risk factors for mortality among adult patients with newly diagnosed tuberculosis in Samara, Russia. Int J Tuberc Lung Dis. 2006;10:1224–1230
  23. Datta M, Radhamani MP, Selvaraj R, Paramasivan CN, Gopalan BN, Sudeendra CR, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuber Lung Dis. 1993;74:180–186

PII: S1201-9712(08)01462-8

doi: 10.1016/j.ijid.2008.07.015

International Journal of Infectious Diseases
Volume 13, Issue 3 , Pages 362-368 , May 2009

Article Tools